...
首页> 外文期刊>Frontiers in Immunology >Improved Efficacy of Oral Immunotherapy Using Non-Digestible Oligosaccharides in a Murine Cow’s Milk Allergy Model: A Potential Role for Foxp3+ Regulatory T Cells
【24h】

Improved Efficacy of Oral Immunotherapy Using Non-Digestible Oligosaccharides in a Murine Cow’s Milk Allergy Model: A Potential Role for Foxp3+ Regulatory T Cells

机译:在小鼠牛的牛奶过敏模型中使用非消化性低聚糖提高口服免疫治疗的功效:Foxp3 +调节性T细胞的潜在作用

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Oral immunotherapy (OIT) is a promising therapeutic approach to treat food allergic patients. However, there are some concerns regarding its safety and long-term efficacy. The use of non-digestible oligosaccharides might improve OIT efficacy since they are known to directly modulate intestinal epithelial and immune cells in addition to acting as prebiotics. Aim To investigate whether a diet supplemented with plant-derived fructo-oligosaccharides (FOS) supports the efficacy of OIT in a murine cow’s milk allergy model and to elucidate the potential mechanisms involved. Methods After oral sensitization to the cow’s milk protein whey, female C3H/HeOuJ mice were fed either a control diet or a diet supplemented with FOS (1% w/w) and received OIT (10?mg whey) 5?days a week for 3?weeks by gavage. Intradermal (i.d.) and intragastric (i.g.) challenges were performed to measure acute allergic symptoms and mast cell degranulation. Blood and organs were collected to measure antibody levels and T cell and dendritic cell populations. Spleen-derived T cell fractions (whole spleen- and CD25-depleted) were transferred to na?ve recipient mice to confirm the involvement of regulatory T cells (Tregs) in allergy protection induced by OIT?+?FOS. Results OIT?+?FOS decreased acute allergic symptoms and mast cell degranulation upon challenge and prevented the challenge-induced increase in whey-specific IgE as observed in sensitized mice. Early induction of Tregs in the mesenteric lymph nodes (MLN) of OIT?+?FOS mice coincided with reduced T cell responsiveness in splenocyte cultures. CD25 depletion in OIT?+?FOS-derived splenocyte suspensions prior to transfer abolished protection against signs of anaphylaxis in recipients. OIT?+?FOS increased serum galectin-9 levels. No differences in short-chain fatty acid (SCFA) levels in the cecum were observed between the treatment groups. Concisely, FOS supplementation significantly improved OIT in the acute allergic skin response, %Foxp3+ Tregs and %LAP+ Th3 cells in MLN, and serum galectin-9 levels. Conclusion FOS supplementation improved the efficacy of OIT in cow’s milk allergic mice. Increased levels of Tregs in the MLN and abolished protection against signs of anaphylaxis upon transfer of CD25-depleted cell fractions, suggest a role for Foxp3+ Tregs in the protective effect of OIT?+?FOS.
机译:背景技术口服免疫疗法(OIT)是治疗食物过敏患者的一种有前途的治疗方法。但是,对其安全性和长期疗效存在一些担忧。使用非消化性低聚糖可能会提高OIT功效,因为已知它们除了可以作为益生元外,还可以直接调节肠上皮和免疫细胞。目的探讨补充植物来源的低聚果糖(FOS)的饮食是否支持OIT在鼠奶过敏模型中的功效,并阐明其中的潜在机制。方法对牛乳蛋白乳清口服致敏后,对雌性C3H / HeOuJ小鼠进行对照饮食或补充FOS(1%w / w)的饮食,每周5天接受OIT(10mg乳清)治疗。通过灌胃3周。进行皮内(i.d.)和胃内(i.g.)攻击以测量急性过敏症状和肥大细胞脱粒。收集血液和器官以测量抗体水平以及T细胞和树突细胞群体。将脾源性T细胞级分(整个脾脏和CD25缺失)转移至幼稚的受体小鼠,以确认调节性T细胞(Tregs)参与了由OITβ+ΔFOS诱导的过敏保护。结果OIT + + FOS降低了急性过敏症状,并且在激发后肥大细胞脱粒,并防止了在致敏小鼠中观察到的由激发引起的乳清特异性IgE增加。 OITα+ΔFOS小鼠的肠系膜淋巴结(MLN)中Treg的早期诱导与脾细胞培养物中T细胞反应性降低有关。在转移之前,OITα+ΔFOS脾细胞悬浮液中CD25的消耗被消除,从而避免了对受者过敏反应迹象的保护。 OIT + + FOS增加血清半乳凝素9水平。在治疗组之间,盲肠的短链脂肪酸(SCFA)水平没有差异。简而言之,补充FOS可以显着改善急性过敏性皮肤反应中的OIT,MLN中的%Foxp3 + Tregs和%LAP + Th3细胞以及血清半乳糖凝集素9水平。结论补充FOS可改善OIT对牛奶过敏小鼠的功效。 MLN中Tregs含量的增加,以及在转移CD25耗尽的细胞部分后废除了对过敏反应迹象的保护作用,提示Foxp3 + Tregs在OITα+ΔFOS的保护作用中发挥了作用。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号